Generalizable quantitative imaging and machine learning signatures in glioblastoma, for precision diagnostics and personalized treatment: the ReSPOND consortium

Booth, Thomas (Primary Investigator)

Cancer Imaging

Project: Research

Status	Active
Effective start/end date	1/06/2022 → 31/05/2024

Collaborative partners

King's College London
University of Pennsylvania (lead)

Funding

NIH National Institutes of Health: £22,233.82

1 Article

Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium
ReSPOND Consortium, Lee, M. D., Patel, S. H., Mohan, S., Akbari, H., Bakas, S., Nasrallah, M. P., Calabrese, E., Rudie, J., Villanueva-Meyer, J., LaMontagne, P., Marcus, D. S., Colen, R. R., Balana, C., Choi, Y. S., Badve, C., Barnholtz-Sloan, J. S., Sloan, A. E., Booth, T. C., Palmer, J. D., & 11 othersDicker, A. P., Flanders, A. E., Shi, W., Griffith, B., Poisson, L. M., Chakravarti, A., Mahajan, A., Chang, S., Orringer, D., Davatzikos, C. & Jain, R., Sept 2023, In: Neuroradiology. 65, 9, p. 1343-1352 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
1 Citation (Scopus)

10 Downloads (Pure)